Overview Nicotine Patch Safety Study Status: Completed Trial end date: 2012-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety profile of a repeated application of a new transdermal patch compared to a reference product during 3 weeks, in a large population. Phase: Phase 2 Details Lead Sponsor: Pierre Fabre MedicamentTreatments: Nicotine